Cargando…

Clinical Phenotyping and Biomarkers in Spinal and Bulbar Muscular Atrophy

Background: Spinal and bulbar muscular atrophy (SBMA) or Kennedy disease [OMIM: 313200] is a rare X-linked neuromuscular disease. Patients commonly present with muscle cramps, tremors, leg weakness, dysarthria and dysphagia. Methods: We deeply phenotyped and evaluated the possible extent of affected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Millere, Elina, Rots, Dmitrijs, Glazere, Ieva, Taurina, Gita, Kurjane, Natalja, Priedite, Viktorija, Gailite, Linda, Blennow, Kaj, Zetterberg, Henrik, Kenina, Viktorija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856139/ https://www.ncbi.nlm.nih.gov/pubmed/33551952 http://dx.doi.org/10.3389/fneur.2020.586610

Ejemplares similares

GJB1 Gene Analysis in Two Extended Families with X-Linked Charcot-Marie-Tooth Disease
por: Kovale, Sabine, et al.
Publicado: (2021)

Mother and Daughter with Short Stature, Microcephaly, Mild Dysmorphic Features, and Learning Disabilities Due to Ververi-Brady Syndrome Associated with a New Variant of the QRICH1 Gene
por: Roddate, Marija, et al.
Publicado: (2023)

The most common European HINT1 neuropathy variant phenotype and its case studies
por: Rozevska, Marija, et al.
Publicado: (2023)

Alanyl-tRNA Synthetase 1 Gene Variants in Hereditary Neuropathy: Genotype and Phenotype Overview
por: Setlere, Signe, et al.
Publicado: (2022)

Clinical Symptoms Influencing Parkinson’s Patients’ Quality of Life in Latvia: A Single-Center Cohort Study
por: Minibajeva, Olga, et al.
Publicado: (2023)

National survey on clinical and genetic characteristics of patients with hereditary angioedema in Latvia
por: Kanepa, Adine, et al.
Publicado: (2023)

The First Registered Type 0 Spinal Muscular Atrophy Patient in Latvia: Call for Change in Prenatal Diagnostic Procedures
por: Čupāne, Tīna Luīze, et al.
Publicado: (2023)

Expression of Human Endogenous Retrovirus-K in Spinal and Bulbar Muscular Atrophy
por: Rex, Cody, et al.
Publicado: (2019)

Long-Term Immunological Memory of SARS-CoV-2 Is Present in Patients with Primary Antibody Deficiencies for up to a Year after Vaccination
por: Lucane, Zane, et al.
Publicado: (2023)

Correlation Between Maximal Tongue Pressure and Swallowing Function in Spinal and Bulbar Muscular Atrophy
por: Gwak, Dae-Won, et al.
Publicado: (2021)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Overview of Neuromuscular Disorder Molecular Diagnostic Experience for the Population of Latvia
por: Lace, Baiba, et al.
Publicado: (2022)

Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy
por: Lombardi, Vittoria, et al.
Publicado: (2019)

Mitochondrial abnormalities in spinal and bulbar muscular atrophy
por: Ranganathan, Srikanth, et al.
Publicado: (2009)

Clinical features of spinal and bulbar muscular atrophy
por: Rhodes, Lindsay E., et al.
Publicado: (2009)

Swallowing markers in spinal and bulbar muscular atrophy
por: Banno, Haruhiko, et al.
Publicado: (2017)

The role of ubiquitination in spinal and bulbar muscular atrophy
por: Sengupta, Medha, et al.
Publicado: (2022)

Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review
por: Querin, Giorgia, et al.
Publicado: (2018)

Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome
por: Gailite, Linda, et al.
Publicado: (2018)

Neuropathology and Therapeutic Intervention in Spinal and Bulbar Muscular Atrophy
por: Banno, Haruhiko, et al.
Publicado: (2009)

Current Status of Treatment of Spinal and Bulbar Muscular Atrophy
por: Tanaka, Fumiaki, et al.
Publicado: (2012)

Correlation of clinical and molecular features in spinal bulbar muscular atrophy
por: Fratta, Pietro, et al.
Publicado: (2014)

Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy
por: Hijikata, Yasuhiro, et al.
Publicado: (2016)

Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy
por: Guber, Robert D., et al.
Publicado: (2017)

Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy
por: Guber, Robert D., et al.
Publicado: (2017)

J wave syndromes in patients with spinal and bulbar muscular atrophy
por: Steinmetz, Karoline, et al.
Publicado: (2022)

Exploring the Role of Posttranslational Modifications in Spinal and Bulbar Muscular Atrophy
por: Gogia, Neha, et al.
Publicado: (2022)

Serum Creatine, Not Neurofilament Light, Is Elevated in CHCHD10-Linked Spinal Muscular Atrophy
por: Järvilehto, Julius, et al.
Publicado: (2022)

Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies
por: Lucane, Zane, et al.
Publicado: (2023)

Head and Arm Tremor in X-linked Spinal and Bulbar Muscular Atrophy
por: Aicua, Irene, et al.
Publicado: (2014)

Rapidly Worsening Bulbar Symptoms in a Patient with Spinobulbar Muscular Atrophy
por: Diaz-Abad, Montserrat, et al.
Publicado: (2013)

A randomized controlled trial of exercise in spinal and bulbar muscular atrophy
por: Shrader, Joseph A, et al.
Publicado: (2015)

Genotype-Phenotype Correlation in Chinese Patients with Spinal and Bulbar Muscular Atrophy
por: Ni, Wang, et al.
Publicado: (2015)

Quantitative Assessment of Swallowing Dysfunction in Patients with Spinal and Bulbar Muscular Atrophy
por: Hashizume, Atsushi, et al.
Publicado: (2017)

Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients
por: Borgia, Doriana, et al.
Publicado: (2017)

Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial
por: Yamada, Shinichiro, et al.
Publicado: (2022)

Development of a functional composite for the evaluation of spinal and bulbar muscular atrophy
por: Inagaki, Tomonori, et al.
Publicado: (2022)

Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice
por: Galbiati, Mariarita, et al.
Publicado: (2023)

Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)
por: Yamada, Shinichiro, et al.
Publicado: (2018)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_is5cv4uljsso2b6s7r4b8aot6n